SCM
EW icon

Seascape Capital Management’s Edwards Lifesciences EW Stock Holding History

Seascape Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.66M Buy
45,678
+1,516
+3% +$125K 1.05% 36
2025
Q4 		$3.77M Buy
44,162
+4,784
+12% +$393K 1.07% 38
2025
Q3 		$3.06M Buy
39,378
+5,056
+15% +$395K 0.88% 46
2025
Q2 		$2.68M Sell
34,322
-694
-2% -$51.8K 0.85% 46
2025
Q1 		$2.54M Buy
35,016
+754
+2% +$54K 0.89% 41
2024
Q4 		$2.54M Buy
34,262
+1,273
+4% +$89.1K 0.88% 44
2024
Q3 		$2.18M Buy
32,989
+174
+0.5% +$12.6K 0.78% 47
2024
Q2 		$3.03M Buy
32,815
+1,658
+5% +$147K 1.13% 33
2024
Q1 		$2.98M Buy
31,157
+3,391
+12% +$285K 1.11% 34
2023
Q4 		$2.12M Buy
27,766
+170
+0.6% +$11.8K 0.89% 43
2023
Q3 		$1.91M Buy
27,596
+604
+2% +$48.5K 0.91% 39
2023
Q2 		$2.55M Sell
26,992
-507
-2% -$44.1K 1.21% 35
2023
Q1 		$2.27M Sell
27,499
-58
-0.2% -$4.56K 1.16% 39
2022
Q4 		$2.06M Buy
27,557
+460
+2% +$35.5K 1.12% 41
2022
Q3 		$2.24M Buy
27,097
+333
+1% +$32K 1.53% 27
2022
Q2 		$2.54M Buy
26,764
+68
+0.3% +$7.04K 1.54% 27
2022
Q1 		$3.14M Sell
26,696
-966
-3% -$108K 1.63% 24
2021
Q4 		$3.58M Buy
27,662
+228
+0.8% +$26.6K 1.68% 21
2021
Q3 		$3.11M Buy
27,434
+620
+2% +$70.8K 1.59% 20
2021
Q2 		$2.78M Sell
26,814
-327
-1% -$30.8K 1.45% 22
2021
Q1 		$2.27M Sell
27,141
-2,639
-9% -$223K 1.26% 33
2020
Q4 		$2.72M Sell
29,780
-90
-0.3% -$7.46K 1.59% 16
2020
Q3 		$2.38M Sell
29,870
-384
-1% -$30K 1.51% 14
2020
Q2 		$2.09M Buy
+30,254
New +$2.15M 1.5% 17

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Seascape Capital Management's EW Position: Q1 2026 in Review

Seascape Capital Management increased its Edwards Lifesciences (EW) stake by 3.4% in Q1 2026, buying an estimated $125K and bringing the position to 45,678 shares worth $3.66M. The position accounts for 1.05% of the portfolio, ranked #36.

Seascape Capital Management first reported a position in EW in Q2 2020 and has held it in 24 quarters since. The position peaked at $3.77M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Seascape Capital Management held 45,678 shares of Edwards Lifesciences worth $3.66M as of Q1 2026.
  • Seascape Capital Management bought 1,516 Edwards Lifesciences shares in Q1 2026, an estimated $125K.
  • Edwards Lifesciences made up 1.05% of Seascape Capital Management's portfolio in Q1 2026, its #36 holding.
  • Seascape Capital Management first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 24 quarters since.
  • Seascape Capital Management's Edwards Lifesciences position peaked at $3.77M in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Seascape Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.